← Back to Search

Behavioural Intervention

Asymmetric Walking Protocols for ACL Reconstruction

N/A

Recruiting

Led By Kristin Morgan, PhD

Research Sponsored by University of Connecticut

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post-treatment (immediately following the completion of the second session)

Awards & highlights

Study Summary

This trial seeks to find ways to restore healthy symmetric walking after ACLR surgery using asymmetric walking protocols & machine learning.

Who is the study for?

This trial is for individuals aged 18-30 who have undergone ACL reconstruction at the UConn Musculoskeletal Institute and are cleared to return to sport. They must show a significant difference in limb loading when walking, speak English, and not have other injuries or conditions that affect movement.Check my eligibility

What is being tested?

The study tests two different asymmetric walking speeds (0.25 m/s and 0.50 m/s) first on people after ACL surgery to see which better restores balanced limb loading. It uses computational models and machine learning to analyze knee loading.See study design

What are the potential side effects?

Since this trial involves physical activity protocols rather than drugs, side effects may include discomfort or fatigue due to the walking sessions but should not involve typical medication-related side effects.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post-treatment (immediately following the completion of the second session)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post-treatment (immediately following the completion of the second session)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-treatment (immediately following the completion of the second session) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Knee Loading

Change in Loading Rate

Change in Peak Vertical Ground Reaction Force

+1 more

Trial Design

2Treatment groups

Active Control

Group I: 0.25 m/s asymmetric session firstActive Control1 Intervention

Participants will perform three 15-minute sessions of walking with a 0.25 m/s asymmetric walking gait speed difference where one limb is set at 1.0 m/s and the other limb is set at 1.25 m/s. Each of these sessions will be followed by 5-minute de-adaptation sessions where they will perform a symmetric walking trial at 1.0 m/s.

Group II: 0.50 m/s asymmetric walking session firstActive Control1 Intervention

Participants will perform three 15-minute sessions of walking with a 0.50 m/s asymmetric walking gait speed difference where one limb is set at 1.0 m/s and the other limb is set at 1.5 m/s. Each of these sessions will be followed by 5-minute de-adaptation sessions where they will perform a symmetric walking trial at 1.0 m/s.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of ConnecticutLead Sponsor

184 Previous Clinical Trials

158,253 Total Patients Enrolled

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH

485 Previous Clinical Trials

1,086,860 Total Patients Enrolled

1 Trials studying Anterior Cruciate Ligament Reconstruction

1,236 Patients Enrolled for Anterior Cruciate Ligament Reconstruction

Kristin Morgan, PhDPrincipal InvestigatorUniversity of Connecticut

Media Library

Asymmetric Walking Protocol (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05968729 — N/A

Anterior Cruciate Ligament Reconstruction Research Study Groups: 0.25 m/s asymmetric session first, 0.50 m/s asymmetric walking session first

Anterior Cruciate Ligament Reconstruction Clinical Trial 2023: Asymmetric Walking Protocol Highlights & Side Effects. Trial Name: NCT05968729 — N/A

Asymmetric Walking Protocol (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05968729 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for individuals to become involved in this research endeavor?

"According to information hosted on clinicaltrials.gov, this trial is actively recruiting participants and was first posted on September 1st 2022, with the most recent update occurring in July 27th 2023."

Answered by AI

Am I able to enroll in this clinical exploration?

"Patients who have had anterior cruciate ligament reconstruction surgery, and are between 18 to 30 years of age, can be eligible for this clinical study. In total the trial is recruiting 40 individuals."

Answered by AI

What is the limit of participants for this medical experiment?

"Affirmative. Information posted on clinicaltrials.gov corroborates that this study is actively recruiting participants. The trial was first published in September 2020 and the specifications were most recently updated at the end of July 2021, requiring 40 volunteers from a single site."

Answered by AI

Does this study permit participants younger than 55 years old?

"Those who wish to be included in this medical study must have an age between 18 and 30. Moreover, lesser-aged patients (18 or under) and senior citizens (65 or above) can participate in separate trials dedicated for their respective ages."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol

Kristin Morgan 2022. "Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05968729.